Skip to content

Category: society

President Trump’s April 15 Executive Order: Implications for Drug Pricing, Biopharma Innovation, and Medicare Beneficiaries

President Trump’s April 15 executive order seeks to delay Medicare price negotiations for small molecule drugs, aiming to balance innovation incentives with cost savings for beneficiaries.

Leave a Comment